Javier Z. Martin-Broto

Oncology
160 E 53rd St
New York, NY 10022

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 183 publications

TANGENT study design: a phase III, randomized study of emactuzumab for the treatment of tenosynovial giant cell tumors.

TANGENT study design: a phase III, randomized study of emactuzumab for the treatment of tenosynovial giant cell tumors.

Journal: Future oncology (London, England)
Published: July 20, 2026

ASO Visual Abstract: First-in-Human Study of CEB-01: Novel Loco-Regional SN-38-Releasing Membrane to Prevent Local Recurrence in Retroperitoneal Sarcomas.

ASO Visual Abstract: First-in-Human Study of CEB-01: Novel Loco-Regional SN-38-Releasing Membrane to Prevent Local Recurrence in Retroperitoneal Sarcomas.

Journal: Annals of surgical oncology
Published: April 15, 2026

Recurrent retroperitoneal sarcoma: beyond resectability toward a biology-based therapeutic framework.

Recurrent retroperitoneal sarcoma: beyond resectability toward a biology-based therapeutic framework.

Journal: Oncology reviews
Published: April 03, 2026

Biomarkers of prognosis and pazopanib response in soft tissue sarcoma: An exploratory analysis.

Biomarkers of prognosis and pazopanib response in soft tissue sarcoma: An exploratory analysis.

Journal: Therapeutic advances in medical oncology
Published: March 17, 2026

Pooled safety analysis of lurbinectedin plus irinotecan in patients with advanced solid tumors.

Pooled safety analysis of lurbinectedin plus irinotecan in patients with advanced solid tumors.

Journal: Investigational new drugs
Published: March 12, 2026

Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations.

Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations.

Journal: JAMA oncology
Published: February 26, 2026

Feasibility and activity of concurrent neoadjuvant chemotherapy and radiation therapy in patients with high-risk soft tissue sarcoma.

Feasibility and activity of concurrent neoadjuvant chemotherapy and radiation therapy in patients with high-risk soft tissue sarcoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 05, 2026

Brigimadlin Versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety and Translational Data from Brightline-1, a Randomized Phase 2/3 Trial.

Brigimadlin Versus Doxorubicin in Advanced Dedifferentiated Liposarcoma: Efficacy, Safety and Translational Data from Brightline-1, a Randomized Phase 2/3 Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 04, 2026

Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-Line Treatment for Patients with Undifferentiated Pleomorphic Sarcoma.

Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-Line Treatment for Patients with Undifferentiated Pleomorphic Sarcoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 05, 2026

First-in-Human Study of CEB-01: Novel Loco-Regional SN-38-Releasing Membrane to Prevent Local Recurrence in Retroperitoneal Sarcomas.

First-in-Human Study of CEB-01: Novel Loco-Regional SN-38-Releasing Membrane to Prevent Local Recurrence in Retroperitoneal Sarcomas.

Journal: Annals of surgical oncology
Published: December 19, 2025

Histopathologic Diagnostic Agreement Study in Bone and Soft Tissue Tumors: The SELNET Sarcoma Network Experience.

Histopathologic Diagnostic Agreement Study in Bone and Soft Tissue Tumors: The SELNET Sarcoma Network Experience.

Journal: JCO global oncology
Published: December 15, 2025

IMMUNOSARC II Master Trial: Phase II Study of Sunitinib and Nivolumab in Clear Cell Sarcoma Cohort.

IMMUNOSARC II Master Trial: Phase II Study of Sunitinib and Nivolumab in Clear Cell Sarcoma Cohort.

Journal: Cancer communications (London, England)
Published: November 13, 2025
Showing 1-12 of 183

Last Updated: 09/26/2026